Strategies to Uplift Novel Mendelian Gene Discovery for Improved Clinical Outcomes

22Citations
Citations of this article
44Readers
Mendeley users who have this article in their library.

Abstract

Rare genetic disorders, while individually rare, are collectively common. They represent some of the most severe disorders affecting patients worldwide with significant morbidity and mortality. Over the last decade, advances in genomic methods have significantly uplifted diagnostic rates for patients and facilitated novel and targeted therapies. However, many patients with rare genetic disorders still remain undiagnosed as the genetic etiology of only a proportion of Mendelian conditions has been discovered to date. This article explores existing strategies to identify novel Mendelian genes and how these discoveries impact clinical care and therapeutics. We discuss the importance of data sharing, phenotype-driven approaches, patient-led approaches, utilization of large-scale genomic sequencing projects, constraint-based methods, integration of multi-omics data, and gene-to-patient methods. We further consider the health economic advantages of novel gene discovery and speculate on potential future methods for improved clinical outcomes.

Cite

CITATION STYLE

APA

Seaby, E. G., Rehm, H. L., & O’Donnell-Luria, A. (2021, June 17). Strategies to Uplift Novel Mendelian Gene Discovery for Improved Clinical Outcomes. Frontiers in Genetics. Frontiers Media S.A. https://doi.org/10.3389/fgene.2021.674295

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free